DE2753394A1 - Wirkstoffkombination zur selektiven steuerung von immunreaktionen - Google Patents

Wirkstoffkombination zur selektiven steuerung von immunreaktionen

Info

Publication number
DE2753394A1
DE2753394A1 DE19772753394 DE2753394A DE2753394A1 DE 2753394 A1 DE2753394 A1 DE 2753394A1 DE 19772753394 DE19772753394 DE 19772753394 DE 2753394 A DE2753394 A DE 2753394A DE 2753394 A1 DE2753394 A1 DE 2753394A1
Authority
DE
Germany
Prior art keywords
active ingredient
active ingredients
cells
mice
ingredient combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19772753394
Other languages
German (de)
English (en)
Inventor
Walter Dr Pierpaoli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB49826/76A external-priority patent/GB1600119A/en
Application filed by Individual filed Critical Individual
Publication of DE2753394A1 publication Critical patent/DE2753394A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19772753394 1976-11-30 1977-11-30 Wirkstoffkombination zur selektiven steuerung von immunreaktionen Withdrawn DE2753394A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB49826/76A GB1600119A (en) 1976-11-30 1976-11-30 Combination of drugs for the selective control of the immune reactions evoked in a host by the administration of antigens
GB2681777 1977-06-27

Publications (1)

Publication Number Publication Date
DE2753394A1 true DE2753394A1 (de) 1978-06-01

Family

ID=26258445

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772753394 Withdrawn DE2753394A1 (de) 1976-11-30 1977-11-30 Wirkstoffkombination zur selektiven steuerung von immunreaktionen

Country Status (8)

Country Link
US (1) US4310535A (enExample)
JP (1) JPS5396333A (enExample)
CA (1) CA1098829A (enExample)
DE (1) DE2753394A1 (enExample)
FR (1) FR2373287A1 (enExample)
IL (1) IL53452A (enExample)
IT (1) IT1092158B (enExample)
NL (1) NL7713244A (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5447947A (en) * 1990-02-26 1995-09-05 Arc 1 Compositions and methods of treatment of sympathetically maintained pain
US6559186B1 (en) 1990-02-26 2003-05-06 Arc 1, Inc. Compositions and methods of treatment of sympathetically maintained pain
US5070084A (en) * 1990-02-26 1991-12-03 Campbell James N Treatment of sympathetically maintained pain
US5696128A (en) * 1994-07-07 1997-12-09 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method of regulating immune function
US6432401B2 (en) * 2000-05-12 2002-08-13 Novalar Pharmaceuticals, Inc. Local anesthetic methods and kits
US8026266B2 (en) * 2005-11-08 2011-09-27 Arcion Therapeutics, Inc. Treatment of length dependent neuropathy
US9616123B1 (en) * 2012-03-05 2017-04-11 Robert L. Knobler Method and compound for treatment of menopausal symptoms

Also Published As

Publication number Publication date
NL7713244A (nl) 1978-06-01
FR2373287B1 (enExample) 1980-08-22
JPS5396333A (en) 1978-08-23
IT1092158B (it) 1985-07-06
US4310535A (en) 1982-01-12
IL53452A0 (en) 1978-01-31
FR2373287A1 (fr) 1978-07-07
CA1098829A (en) 1981-04-07
IL53452A (en) 1980-12-31

Similar Documents

Publication Publication Date Title
DE69315847T2 (de) Verfahren zur behandlung einer durch lfa-1 vermittelten störung
DE60107065T2 (de) Behandlung des kongestiven herzversagens durch vorbehandeltes autologes blut
EP0217206B1 (de) Arzneimittel gegen chronische Graft-versus-Host-Krankheiten sowie gegen Autoimmunerkrankungen, insbesondere systemischen Lupus erythematodes
DE3218761C2 (enExample)
DE69131386T2 (de) Verwendung von L-Deprenyl zur Hemmung des Alterniedergangs des Immunsystems in Säugetieren
DE69923471T2 (de) Injizierbare propofol-formulierungen
CH692477A5 (de) Zusammensetzung zur Stimulation von Wiederherstellungsvorgängen, enthaltend L-Lysil-L-Glutaminsäure.
DE69723843T2 (de) Verwendung von clotrimazol und verwandte verbindungen zur behandlung von diarrhöe
DD241271A5 (de) Verfahren zur unterscheidung von normalen und boesartigen zellen in einer mischung in vitro
DE3013632A1 (de) Mittel und seine verwendung zur regulierung des knochenmetabolismus
DE1720120A1 (de) Injizierbare Zusatzmittel,Verfahren ihrer Herstellung und Verwendung und neue medizinische Zusammensetzungen,die dieses Zusatzmittel enthalten
DD296843A5 (de) Monoklonale antikoerper zur indukzierung von tobranz
DE69531722T2 (de) Karzinostatische Zusammensetzungen, welche Cis-Oxaliplatin und eine oder mehrere andere verträgliche Karzinostatika enthalten
DE69333413T2 (de) 5-ht2-antagonisten in der behandlung venöser zustände
EP0185210A2 (de) Verwendung von Dipeptidderivaten für die Herstellung von Arzneimitteln zur Behandlung von an amyotropher Lateralsklerose Erkrankten
DE2753394A1 (de) Wirkstoffkombination zur selektiven steuerung von immunreaktionen
EP0214620A2 (de) Transdermale Applikationsform von Diltiazem
DE1967073A1 (de) Inosin-komplexverbindungen
DE69330638T2 (de) Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem
CH650154A5 (de) Wasserloesliche, biologisch aktive fraktion aus dem interzellularen medium des knochenmarks, verfahren zu deren gewinnung und diese enthaltende pharmazeutische zubereitung.
DE2163055A1 (de) Lokalanästhetisches Mittel
DE3737274A1 (de) Verwendung von reinem h2a- und/oder h2b-histon als wirksubstanz zur herstellung von arzneimitteln
DE2528460A1 (de) Verwendung von l-carboxamido-2- cyan-aziridin als immunstimulans
DE3782651T2 (de) Anwendung von n-(2-(diaethylamino)aethyl)-2-methoxy-4((1-h-4,5-dihydro-2-imidazolyl)amino)-5-chlorobenzamid als anxiolytisches und antipsychotisches mittel.
DE69434256T2 (de) Immunglobulin-Infusion bei der Xenotransplantation

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee